JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (1): 80-84.doi: 10.6040/j.issn.1671-7554.0.2016.1114
Previous Articles Next Articles
ZHANG Lin, LI Jing, WANG Ze, ZHANG Jiangtao, MA Zengxiang, SHI Yuhua
CLC Number:
[1] March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria[J]. Hum Reprod, 2010, 25(2): 544-551. [2] Goodarzi MO, Dumesic DA, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis[J]. Nat Rev Endocrinol, 2011, 7(4): 219-231. [3] 詹晶, 许良智. 甲状腺功能异常与多囊卵巢综合征[J/CD]. 中华妇幼临床医学杂志, 2011, 7(4): 309-312. ZHAN Jing, XU Liangzhi. Thyroid function and polycystic ovary syndrome[J/CD]. Chinese Journal of Obstetrics & Gynecology and Pediatrics, 2011, 7(4): 309-312. [4] Benetti-Pinto CL, Berini Piccolo VR, Garmes HM, et al. Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters[J]. Fertil Steril, 2013, 99(2): 588-592. [5] Du D, Li X. The relationship between thyroiditis and polycystic ovary syndrome: a meta-analysis[J]. Int J Clin Exp Med, 2013, 6(10): 880-889. [6] Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS)[J]. Hum Reprod, 2004, 19(1): 41-47. [7] 中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组. 中国甲状腺疾病诊治指南—甲状腺疾病的实验室及辅助检查[J]. 中华内科杂志, 2007, 46(8): 697-702. [8] Enzevaei A, Salehpour S, Tohidi M, et al. Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship?[J]. Iran J Reprod Med, 2014, 12(7): 481-486. [9] Ganie MA, Laway BA, Wani TA, et al. Association of subclinical hypothyroidism and phenotype, insulin resistance, and lipid parameters in young women with polycystic ovary syndrome[J]. Fertil Steril, 2011, 95(6): 2039-2043. [10] Pei YJ, Wang AM, Zhao Y, et al. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism[J]. Gynecol Endocrinol, 2014, 30(8): 553-556. [11] Celik C, Abali R, Tasdemir N, et al. Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?[J]. Gynecol Endocrinol, 2012, 28(8): 615-618. [12] Lambadiari V, Mitrou P, Maratou E, et al. Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes[J]. Endocrine, 2011, 39(1): 28-32. [13] Maratou E, Hadjidakis DJ, Peppa M, et al. Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism[J]. Eur J Endocrinol, 2010, 163(4): 625-630. [14] Meisinger C, Ittermann T, Tiller D, et al. Sex-specific associations between thyrotropin and serum lipid profiles[J]. Thyroid, 2014, 24(3): 424-432. [15] Witte T, Ittermann T, Thamm M, et al. Association between serum thyroid-stimulating hormone levels and serum lipids in children and adolescents: a population-based study of German youth[J]. J Clin Endocrinol Metab, 2015, 100(5): 2090-2097. [16] Song Y, Xu C, Shao S, et al. Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis[J]. J Hepatol, 2015, 62(5): 1171-1179. [17] Asvold BO, Bjøro T, Vatten LJ. Associations of TSH levels within the reference range with future blood pressure and lipid concentrations: 11-year follow-up of the HUNT study[J]. Eur J Endocrinol, 2013, 169(1): 73-82. [18] Åsvold BO, Bjøro T, Platou C, et al. Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT Study in Norway[J]. Clin Endocrinol(Oxf), 2012, 77(6): 911-917. [19] Rodondi N, Aujesky D, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis[J]. Am J Med. 2006, 119(7): 541-51. [20] Ittermann T, Lorbeer R, Dörr M, et al. High levels of thyroid-stimulating hormone are associated with aortic wall thickness in the general population[J]. Eur Radiol, 2016, 26(12): 4490-4496. |
[1] | DING Xiangyun, YU Qingmei, ZHANG Wenfang, ZHUANG Yuan, HAO Jing. Correlation of the expression of insulin-like growth factor II in granulosa cells and ovulation induction outcomes of 84 patients with polycystic ovary syndrome [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 60-66. |
[2] | WANG Meijian, HOU Xinguo, LIANG Kai, CHEN Li. Serum lipids and lipoproteins in middle-aged and elderly Chinese in Shandong Province [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 70-75. |
[3] | ZHANG Suping, WANG Ze, ZHOU Yali, LI Jing, LU Xilan, BAI Hongwei, SHI Yuhua. Clinical effects of body mass index on ovulation induction treatment with letrozole among women with polycystic ovary syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 81-85. |
[4] | YANG Dongzi, MAI Zhuoyao. Features of ovarian reserve and outcomes of assisted reproductive technology in elder patients with PCOS [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 26-32. |
[5] | JIA Yueyue, LIU Hongbin, LI Jingbo, LI Jing, ZHANG Jiangtao, SUN Mei, SHI Yuhua. Expression of microRNA-200b in granulosa cells of PCOS patients and its significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 63-68. |
[6] | LI Jingbo, LIU Hongbin, JIA Yueyue, WANG Ze, SUN Mei, SHI Yuhua. Expression and clinical significance of microRNA-183 in polycystic ovary syndrome with insulin resistance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 69-74. |
[7] | PENG Li, QIANG Ye, ZHAO Huichen, CHEN Shihong, YAO Weidong, LIU Yuantao. Clinical studies on type 2 diabetic patients treated with sitagliptin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 60-63. |
[8] | SHEN Yan, ZUO Changting. Estimation of reference range for thyroid functional parameter in pregnant women of Jinan City, China [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 34-38. |
[9] | PEI Leilei, SUN Zhonghua, LI Zhe, ZHAO Wenping. Effects of sitagliptin combined with high-dose insulin on type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(2): 39-42. |
[10] | XIAN Yuxin, SUN Ruixia, LI Li, LYU Wenshan, CAO Caixia, ZHANG Jietao, WANG Jing, GAO Yanyan. Difference of daily blood glucose profiles in hepatogenous diabetes and type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(8): 63-67. |
[11] | LIU Fangfang1, CHENG Zhenqian2, GAO Ning3, CHEN Shaohua1. Immediate effects of different components of meals with the same energy on the plasma GLP-1, insulin and blood glucose in the newly diagnosed type 2 diabetes patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 41-45. |
[12] | ZHANG Yanling1, ZHANG Xu1, ZHANG Wenwen1, WANG Furong2, YU Chunxiao1, GUAN Qingbo1, YU Guina1, GAO Ling3, ZHAO Jiajun1, XU Jin1. Relationship between serum level of 25-hydroxyvitamin D and fasting blood glucose in healthy adults of Jinan [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(3): 59-63. |
[13] | HA Lingxia, LI Xianghong. Expression and significance of GDF9 and BMP15 in follicular fluid of women with polycysticovary syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(10): 77-80,95. |
[14] | HA Ling-xia1,2, SHI Yu-hua1, ZHAO Jun-li2, CHEN Zi-jiang1. A comparison of lipid metabolism in PCOS patients with different testosterone levels in Ningxia Hui Autonomous Region [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 88-91. |
[15] | ZHANG Wen-wen1, ZHANG Yan-ling1, WANG Jie1, GAO Ling2,YU Chun-xiao1, YAN Hui-li1, XU Jin1. Effects of thyroid stimulating hormone on osteoclast differentiation [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(4): 6-10. |
|